Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the Effects of a Cognitive-Motor Fall Prevention Program "SILVER XIII - EQUILIBRE" on Fall Risk Factors: Functional Abilities and Executive Functions

NCT05625828 is registered in ClinicalTrials.gov with EZUS-LYON 1 as lead sponsor.

NCT NCT05625828
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05625828 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the Effects of a Cognitive-Motor Fall Prevention Program "SILVER XIII - EQUILIBRE" on Fall Risk Factors: Functional Abilities and Executive Functions
Lead sponsor
EZUS-LYON 1
Phase
Not applicable
Overall status
Active, not recruiting
Start date
September 13, 2022
Completion date
October 24, 2025
Enrollment
176 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

accidental falls, aging, mild cognitive impairment